Kyverna Therapeutics, decline in week 13
Kyverna Therapeutics slips 0.6%: sellers still in control but losing ground
Our view last week
Kyverna Therapeutics stock rebounds for a third straight week, +3.1%, but the volume picture is getting sharper: sellers control 63% of trading, up from 56% last week. Money flow, which had been improving for a month, turned lower this week. On the daily chart the stock keeps carving out higher lows, from the 7 area to the 8.1 area. The Sell signal is now in week 12.
This week's summary
Kyverna Therapeutics closes the week down 0.6%, after three weeks of rebound. Sellers still control trading, but only 58%, down from 63% the week before: selling pressure is easing. The last weekly candle is indecisive, with a reduced body, and volumes are contracting. Kyverna Therapeutics stock remains in our technical analysis coverage as a sell signal now in its 13th week.
IQS Phase
49
ordinary
Signal Strength
2
decline fading out
Sizing
MINIMUM
Ranking
#92 / 96
US stocks
Trade P&L %
-12.05%
from signal to date, no stop loss
Rank position
ranks 92nd among the 96 sell signals for US stocks in our ranking, with a signal strength of 2 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -1.98% · monthly +2.96%
KYTX belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content